Named after Denis Parsons Burkitt, a surgeon working in equatorial Africa, Burkitt’s lymphoma (also Burkitt lymphoma or Burkitt’s tumor) is a non-Hodgkin type of lymphoma first described in 1956. It is relatively rare and affects the patient’s B lymphocytes. The signs and symptoms of Burkitt’s lymphoma are similar to other lymphatic cancers.
In general, Burkitt’s lymphoma affeccts children and young adults, and tends to be present in boys more often than women. Broadly speaking, there are two varieties of Burkitt’s lymphoma, endemic and sporadic.
A distinctive feature of this cancer is that it tends to disproportionately affect the jawbone or other facial bones, as well as the distal ileum, cecum, ovaries, or kidneys. Cancerous growths in the jawbone are very rare in the second form the disease.
There is a third type, immunodeficiency-associated Burkitt’s, that is not recognized by all oncologists. It occurs in AIDS patients or in those who are receiving immunosuppressive drugs after a transplant.
Burkitt’s lymphoma is a fast-spreading cancer, and chemotherapy must be started immediately upon diagnosis. It is, however, a relatively curable form of lymphoma, responding well to aggressive chemotherapy, with a survival rate of nearly 80 percent of localized cases and over half of widespread cases.